Healthcare provider profile · identity verified

Stephen Walter Hill, MD

Family Practice · BLOOMINGTON, IL · NPI 1427360429

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	287	83
Lisinopril	Lisinopril	212	58
Amlodipine Besylate	Amlodipine Besylate	177	53
Metformin Hcl	Metformin Hcl	172	44
Levothyroxine Sodium	Levothyroxine Sodium	168	43
Losartan Potassium	Losartan Potassium	128	37
Omeprazole	Omeprazole	120	32
Tamsulosin Hcl	Tamsulosin Hcl	91	25
Bupropion Xl	Bupropion Hcl	90	21
Pantoprazole Sodium	Pantoprazole Sodium	89	25
Fluoxetine Hcl	Fluoxetine Hcl	84	16
Duloxetine Hcl	Duloxetine Hcl	82	16
Metoprolol Tartrate	Metoprolol Tartrate	82	19
Jardiance	Empagliflozin	81	15
Rosuvastatin Calcium	Rosuvastatin Calcium	71	30
Gabapentin	Gabapentin	69	22
Hydrochlorothiazide	Hydrochlorothiazide	69	20
Montelukast Sodium	Montelukast Sodium	68	17
Simvastatin	Simvastatin	68	22
Metoprolol Succinate	Metoprolol Succinate	67	25
Allopurinol	Allopurinol	64	18
Pregabalin	Pregabalin	63	13
Famotidine	Famotidine	58	15
Pravastatin Sodium	Pravastatin Sodium	57	17
Alprazolam	Alprazolam	55	13
Carvedilol	Carvedilol	54	18
Sertraline Hcl	Sertraline Hcl	53	14
Eliquis	Apixaban	52	12
Ozempic	Semaglutide	51	suppressed
Tramadol Hcl	Tramadol Hcl	47	20
Potassium Chloride	Potassium Chloride	46	13
Metformin Hcl Er	Metformin Hcl	45	17
Albuterol Sulfate Hfa	Albuterol Sulfate	43	15
Glipizide Er	Glipizide	42	12
Trazodone Hcl	Trazodone Hcl	42	12
Fluticasone Propionate	Fluticasone Propionate	39	15
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Furosemide	Furosemide	36	15
Synthroid	Levothyroxine Sodium	33	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Methylprednisolone	Methylprednisolone	23	19
Cephalexin	Cephalexin	22	21
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Baclofen	Baclofen	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Naproxen	Naproxen	18	suppressed
Atenolol	Atenolol	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Glipizide	Glipizide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Finasteride	Finasteride	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Topiramate	Topiramate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error